It is well known that nCRT is closely related to the immunogenetic changes of tumor and the tumor microenvironment in EC. Programmed cell death-ligand 1 (PD-L1) was overexpressed in 43.7% of ESCC patients (74). The gene discussed is CD274; the disease is neoplasm.